Randomized, multicenter, open-labeled, two-arm parallel group trial of pitavastatin 2 mg OD for reducing the risk of major cardiovascular events in patients with clustering cardiovascular risk factors

Trial Profile

Randomized, multicenter, open-labeled, two-arm parallel group trial of pitavastatin 2 mg OD for reducing the risk of major cardiovascular events in patients with clustering cardiovascular risk factors

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top